Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
2.440
-0.230 (-8.61%)
Mar 6, 2026, 4:00 PM EST - Market closed

LIXT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
215581639
Market Cap Growth
585.74%-13.62%-37.74%-48.10%-58.39%-13.77%
Enterprise Value
18.377.034.586.6415.0337.75
Last Close Price
2.442.032.355.1011.9031.70
PE Ratio
--1.28-0.88-1.28-2.38-10.93
PB Ratio
5.905.521.321.643.417.84
P/TBV Ratio
1.695.521.131.563.357.13
P/FCF Ratio
--1.44-1.23-1.84-3.95-18.45
P/OCF Ratio
--1.44-1.23-1.84-3.95-18.45
EV/EBITDA Ratio
--1.97-0.90-1.05-2.24-11.56
EV/EBIT Ratio
--1.97-0.90-1.05-2.24-11.56
EV/FCF Ratio
--2.22-1.07-1.44-3.63-17.71
Net Debt / Equity Ratio
-0.59-1.26-1.05-1.04-1.01-1.01
Net Debt / EBITDA Ratio
0.740.290.830.850.721.55
Net Debt / FCF Ratio
1.120.330.981.161.162.38
Quick Ratio
5.543.2613.3913.5315.9223.41
Current Ratio
10.423.6013.7314.0516.8124.15
Return on Equity (ROE)
-142.29%-148.73%-111.07%-126.81%-137.28%-87.69%
Return on Assets (ROA)
-118.45%-131.01%-103.15%-118.48%-130.22%-82.69%
Return on Invested Capital (ROIC)
-334.01%25266.36%13615.90%-61843.92%-107777.16%6438.68%
Return on Capital Employed (ROCE)
-135.78%-148.19%-111.14%-126.79%-137.12%-87.74%
Earnings Yield
-19.45%-78.33%-113.19%-78.24%-42.02%-9.15%
FCF Yield
--69.31%-81.22%-54.32%-25.33%-5.42%
Buyback Yield / Dilution
-9.42%0.00%-59.47%-60.56%-23.89%-11.71%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q